← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2011Last known activity
Dec 1, 2023
Timeline
2000s
- Jun 1, 2002
EpicentRx, Inc.— Founded
Drugs by trial phase (12 distinct, 16 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Small Cell
- Central Nervous System Neoplasms
- Cholangiocarcinoma
- Colorectal Neoplasms
- Glioblastoma
- Lung Neoplasms
- Lymphoma
- Mucositis
- Neoplasm Metastasis
- Neoplasms
- Nervous System Neoplasms
- Neuroendocrine Tumors
- Oligodendroglioma
- Small Cell Lung Carcinoma
- Stomatitis
Recent trials (24)
- NCT03529539Lead sponsorN/A—
- NCT05966194Study directorPhase 2Dec 1, 2023
- NCT05966194Lead sponsorPhase 2Dec 1, 2023
- NCT05566041Lead sponsorPhase 3Aug 1, 2022
- NCT04673942Lead sponsorPhase 1Mar 29, 2021
- NCT04673942Study directorPhase 1Mar 29, 2021
- NCT04525014Lead sponsorPhase 1Sep 1, 2020
- NCT04525014Study directorPhase 1Sep 1, 2020
- NCT03699956Study directorPhase 3Dec 24, 2018
- NCT03699956Lead sponsorPhase 3Dec 24, 2018
- NCT03515538Lead sponsorPhase 2Jul 12, 2018
- NCT03515538Study directorPhase 2Jul 12, 2018
- NCT02801097Study directorPhase 1Oct 1, 2016
- NCT02801097Lead sponsorPhase 1Oct 1, 2016
- NCT02871843Lead sponsorPhase 1Aug 1, 2016
Details
- Founded
- Mountain View, CA, US Jun 1, 2002
- Last known activity
- Dec 1, 2023